Solriamfetol
IGN-B0301-03
Phase 3 small_molecule completed
Quick answer
Solriamfetol for Sleep Apnea, Obstructive is a Phase 3 program (small_molecule) at Ignis Therapeutics (Suzhou) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ignis Therapeutics (Suzhou) Limited
- Indication
- Sleep Apnea, Obstructive
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed